ICREA Academia 2024. RNA-based therapeutics. Cristina Fornaguera

This project presents a strong and innovative approach to critical medical challenges in oncology, neurodegenerative diseases, and pregnancy-related conditions through the development of a versatile nanoparticle platform with clear potential to advance RNA-based therapeutics.

The proposal is well-founded, supported institutionally, and includes adequate risk management, reflecting a solid scientific and strategic basis. The candidate demonstrates notable expertise in nanoparticle-based therapies and has already contributed significant advances in therapeutic delivery, complemented by effective leadership of research teams and engagement in the broader scientific community. While the project’s translational potential is high, its long-term impact could be further enhanced by deepening international collaborations, strengthening regulatory interactions, and increasing participation in policy and high-level strategic discussions to reinforce the candidate’s trajectory as a leader in nanomedicine.

This project has been awarded under the 2024 ICREA Call (Agaur, Generalitat de Catalunya)